Related Experiment Video
Updated: Aug 16, 2026

Functional Cloning Using a Xenopus Oocyte Expression System
Published on: January 30, 2016
Ipsogen
1Scientific Advisory Board, Ipsogen, Luminy Biotech Entreprises, Case 923, 163 Avenue de Luminy,13288 Marseille, France. jordan@genopole.univ-mrs.fr.
Abstract:
Ipsogen is a molecular diagnostics company focused on the development and commercialization of innovative tests used to guide and personalize treatment options in cancer. Ipsogen has built a comprehensive portfolio of unique blood cancer diagnostic products available worldwide to leading cancer care institutions in more than 50 countries. Ipsogen's core expertise is focused on large-scale gene expression profiling of tumors in a clinical context, and includes proven know-how for the translation of discoveries into industry standard diagnostic tools. This is achieved, for blood cancers, by an array of individual DNA or RNA tests targeting known anomalies, and for breast cancer by expression profiling and interpretation of the results on the basis of extensive retrospective and prospective studies performed by the company. These products and services make personalized cancer treatment both possible and effective.
Related Concept Videos
In-vitro Mutagenesis
In vitro Mutagenesis
In-situ Hybridization
Types of probes and labels
A probe is a complementary strand of DNA or RNA that binds to corresponding nucleotide sequences in a cell. Many...
Ion Exchange
Insensitive Nuclei Enhanced by Polarization Transfer (INEPT)
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

